FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032591736> ?p ?o ?g. }

• W2032591736 endingPage "9" @default.
• W2032591736 startingPage "2" @default.
• W2032591736 abstract "The estrogen steroid hormone receptor (ER) and human epithelial growth factor receptor 2 membrane tyrosine kinase growth factor receptor (HER2) are the mediators of two key pathways involved in breast carcinogenesis, invasive behavior and cell growth. Co-expression of these receptors results in specific biological features that are not fully understood, but include relative resistance to hormonal therapy and chemotherapy as well as better long-term outcome imparted by ER and worse outcome by HER2 expression. The ER and HER2 signaling pathways interact with each other as do many biological networks, and this creates opportunities for therapeutic co-targeting with agents that modulate these respective pathways. However, relatively few studies have been conducted to test concurrent manipulation of ER and HER2. The avoidance of chemotherapy side effects is an attractive feature that has further spurred explorations in this strategy. Still, the only dually targeted strategy approved by some regulatory agencies is the combination of hormonal therapy using aromatase inhibition and the HER2 kinase inhibitor lapatinib. Other dual combinations have also demonstrated a benefit, although most of the testing has compared hormonal therapy with or without HER2-directed agents and not the other way around, limiting the applicability of this concept in routine clinical practice, especially when chemotherapy is also used. Newer generation signal transduction inhibitors can augment the efficacy of hormonal therapy, with one such example of mTOR blockade using everolimus now in the clinic. The logical extension of ER and HER2 co-targeting is the discovery and clinical testing of “synthetic lethal” combinations attacking diverse pathways that produce quantum improvements over either therapy alone. Molecular annotation of human cancers can further inform personalized combinatorial regimens based on the unique circuitry of an individual patient's tumor, with the potential to yield much more than incremental gains in survival." @default.
• W2032591736 created "2016-06-24" @default.
• W2032591736 creator A5023674071 @default.
• W2032591736 creator A5023849192 @default.
• W2032591736 date "2014-02-01" @default.
• W2032591736 modified "2023-10-01" @default.
• W2032591736 title "Co-targeting estrogen receptor and HER2 pathways in breast cancer" @default.
• W2032591736 cites W1595886999 @default.
• W2032591736 cites W1927418190 @default.
• W2032591736 cites W1976250589 @default.
• W2032591736 cites W1977221327 @default.
• W2032591736 cites W1982729445 @default.
• W2032591736 cites W1990883066 @default.
• W2032591736 cites W1996920020 @default.
• W2032591736 cites W1997042214 @default.
• W2032591736 cites W2012784647 @default.
• W2032591736 cites W2013956549 @default.
• W2032591736 cites W2015473392 @default.
• W2032591736 cites W2022102157 @default.
• W2032591736 cites W2035059302 @default.
• W2032591736 cites W2039976295 @default.
• W2032591736 cites W2040077715 @default.
• W2032591736 cites W2045324973 @default.
• W2032591736 cites W2046410395 @default.
• W2032591736 cites W2061551473 @default.
• W2032591736 cites W2062713892 @default.
• W2032591736 cites W2064823103 @default.
• W2032591736 cites W2074062119 @default.
• W2032591736 cites W2094438226 @default.
• W2032591736 cites W2095865154 @default.
• W2032591736 cites W2096655031 @default.
• W2032591736 cites W2096884232 @default.
• W2032591736 cites W2097698108 @default.
• W2032591736 cites W2098775844 @default.
• W2032591736 cites W2105095453 @default.
• W2032591736 cites W2106286200 @default.
• W2032591736 cites W2108863890 @default.
• W2032591736 cites W2110444464 @default.
• W2032591736 cites W2111578514 @default.
• W2032591736 cites W2113458582 @default.
• W2032591736 cites W2114167623 @default.
• W2032591736 cites W2117357260 @default.
• W2032591736 cites W2117873881 @default.
• W2032591736 cites W2117984780 @default.
• W2032591736 cites W2118728607 @default.
• W2032591736 cites W2123591186 @default.
• W2032591736 cites W2125620887 @default.
• W2032591736 cites W2133503038 @default.
• W2032591736 cites W2138317169 @default.
• W2032591736 cites W2140055441 @default.
• W2032591736 cites W2141232624 @default.
• W2032591736 cites W2141393790 @default.
• W2032591736 cites W2143724133 @default.
• W2032591736 cites W2143937001 @default.
• W2032591736 cites W2146308386 @default.
• W2032591736 cites W2146378328 @default.
• W2032591736 cites W2146383973 @default.
• W2032591736 cites W2146384083 @default.
• W2032591736 cites W2147299492 @default.
• W2032591736 cites W2148479421 @default.
• W2032591736 cites W2149773268 @default.
• W2032591736 cites W2149908785 @default.
• W2032591736 cites W2151101674 @default.
• W2032591736 cites W2154488022 @default.
• W2032591736 cites W2156402569 @default.
• W2032591736 cites W2159459001 @default.
• W2032591736 cites W2159967578 @default.
• W2032591736 cites W2164484108 @default.
• W2032591736 cites W2164541907 @default.
• W2032591736 cites W2166199281 @default.
• W2032591736 cites W2167188058 @default.
• W2032591736 cites W2169052701 @default.
• W2032591736 cites W2170241131 @default.
• W2032591736 cites W2318605753 @default.
• W2032591736 cites W4239989216 @default.
• W2032591736 cites W4249434837 @default.
• W2032591736 cites W4293395719 @default.
• W2032591736 doi "https://doi.org/10.1016/j.breast.2013.09.006" @default.
• W2032591736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24176518" @default.
• W2032591736 hasPublicationYear "2014" @default.
• W2032591736 type Work @default.
• W2032591736 sameAs 2032591736 @default.
• W2032591736 citedByCount "38" @default.
• W2032591736 countsByYear W20325917362014 @default.
• W2032591736 countsByYear W20325917362015 @default.
• W2032591736 countsByYear W20325917362016 @default.
• W2032591736 countsByYear W20325917362017 @default.
• W2032591736 countsByYear W20325917362018 @default.
• W2032591736 countsByYear W20325917362019 @default.
• W2032591736 countsByYear W20325917362020 @default.
• W2032591736 countsByYear W20325917362021 @default.
• W2032591736 countsByYear W20325917362022 @default.
• W2032591736 countsByYear W20325917362023 @default.
• W2032591736 crossrefType "journal-article" @default.
• W2032591736 hasAuthorship W2032591736A5023674071 @default.
• W2032591736 hasAuthorship W2032591736A5023849192 @default.
• W2032591736 hasBestOaLocation W20325917361 @default.
• W2032591736 hasConcept C101544691 @default.

• next